#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leukoencephalopathy Familial hypertriglyceridaemia Leukodystrophy Cardiac sarcoidosis Cholangitis sclerosing Frostbite Metastases to central nervous system Atypical haemolytic uraemic syndrome Lip and/or oral cavity cancer Restless legs syndrome Angiosarcoma recurrent Biotinidase deficiency Frontotemporal dementia Chronic hepatitis B Graft versus host disease More trials…

    Learn about Rare Diseases

    Combined immunodeficiency – Treatment Urea cycle disorder – Diagnostics Noonan syndrome – Treatment Paroxysmal nocturnal haemoglobinuria – Treatment Metachromatic leukodystrophy CADASIL – Diagnostics Angelman’s syndrome – Basic Information Mantle cell lymphoma stage III – Diagnostics Lysosomal storage disorder Chondrosarcoma metastatic – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cyanocobalamin Etidronate Disodium Juniper Berry Oil Chlorambucil Lerodalcibep ZAMPILIMAB GSKVX000000025896 Camonsertib Adrenaline Acid Tartrate Bp Brepocitinib Tosilate Collagenase GT-002 Histamine Hydrochloride Mk-0482 Mepacrine L-SERINE Sorafenib Efavirenz Ngi226 WEF-001 More therapies…

    Learn about Your Condition

    Primary myelofibrosis Testis cancer Adenocarcinoma Intracranial calcification Psychogenic seizure Polymyalgia rheumatica Prostate cancer Congenital pseudarthrosis Breast cancer metastatic Cardiac disorder Bronchiolitis Tympanic membrane hyperaemia Uterine cancer Venous thrombosis limb Allergic respiratory disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effects of Doxorubicin and Temozolomide After Radiotherapy in Children and Young Adults with Glioblastoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Doxorubicin Hydrochloride
    • Temozolomide
    Italy

  • Study on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions

    Not recruiting

    3 1
    Investigated Drugs:
    • Pelacarsen
    Austria Belgium Bulgaria Czechia Denmark France +14

  • Study on Metoprolol for Preventing Heart Disease in Boys with Duchenne Muscular Dystrophy Aged 8-17

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Metoprolol Tartrate
    Poland

  • Study of RMC-6236 compared to standard therapy in previously treated metastatic pancreatic ductal adenocarcinoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Irinotecan Hydrochloride
    • (12M)-(1S,2S)-N-((63S,4S,Z)-11-ETHYL-12-(2-((S)-1-METHOXYETHYL)-5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)-10,10-DIMETHYL-5,7-DIOXO-61,62,63,64,65,66-HEXAHYDRO-11H-8-OXA-2(4,2)-THIAZOLA-1(5,3)-INDOLA-6(1,3)-PYRIDAZINACYCLOUNDECAPHANE-4-YL)-2-METHYLCYCLOPROPANE-1-CARBOXAMIDE
    • Fluorouracil
    France Germany Italy Spain

  • Study of TX000045 for Pulmonary Hypertension in Heart Failure Patients with Preserved Ejection Fraction

    Not recruiting

    2 1
    Investigated Drugs:
    • TX000045
    Austria Belgium Bulgaria Germany Latvia Poland +3

  • Study on the Effects and Safety of Guselkumab for Patients with Active Psoriatic Arthritis

    Not recruiting

    3 1
    Investigated Drugs:
    • Guselkumab
    Bulgaria Croatia Czechia Estonia Germany Greece +8
Previous Page
1 … 1,634 1,635 1,636 1,637 1,638 … 1,645
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!